BB-201

N/A

Report date: 2024/11/05 16:40:48
NME

Base Information

Drug NameBB-201
Drug Alias NameBB-AMD-211TT-211TT-231BB-201
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionPlacental Growth Factor inhibitorsVascular endothelial growth factor B inhibitors
TargetsPlacental Growth FactorVascular endothelial growth factor B
Therapy Area/IndicationsWet age-related macular degenerationMacular Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTacere Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesTacere Therapeutics IncBenitec Biopharma Ltd
Inactive CompaniesN/A
Active IndicationsWet age-related macular degenerationMacular Degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A